Laissez Faire Economics

Bambusa Therapeutics Upsizes IPO, Prices at $16, and Stock Drops

Boston-based biotech firm Bambusa Therapeutics (BBTX) successfully upsized and priced its initial public offering at $16.00 per share, the mid-point…

Architect of Empire, Harbinger of Famine: The Legacy of Sir Charles Trevelyan

Sir Charles Edward Trevelyan, 1st Baronet (1807–1886) stands as one of the most polarized figures in the history of British…